Headaches in HIV infection - Epidemiology, pathophysiology and treatment

Citation
B. Wibbeke et al., Headaches in HIV infection - Epidemiology, pathophysiology and treatment, SCHMERZ, 14(4), 2000, pp. 245-251
Citations number
54
Categorie Soggetti
Neurology
Journal title
SCHMERZ
ISSN journal
0932433X → ACNP
Volume
14
Issue
4
Year of publication
2000
Pages
245 - 251
Database
ISI
SICI code
0932-433X(200008)14:4<245:HIHI-E>2.0.ZU;2-T
Abstract
Headache and HIV infection. Headache is one of the most common pain syndrom es in HIV infection. The prevalence of headache in HIV infected patients in the published cross-sectional and longitudinal studies is between 3.8% and 47.4% depending on the study methodology and the study subpopulation. In t his review, we analyse these cross-sectional and longitudinal studies and t he case reports of headache in HIV infection. Both primary headache, such a s migraine or tension-type headache,and secondary headache, e. g. caused by opportunistic infections or neoplasms, can be observed. in addition,there is a so-called "HIV headache" which develops de novo during the HIV infecti on, the cause of this headache type is still unclear. Migraine shows an ame lioration during the course of the HIV infection whereas tension-type heada che shows a deteriotation. In some patients, however, tension-type headache cannot be differentiated from HIV-headache. Therapy. The therapeutic management of headache during the HIV infection is the same as in non-infected subjects. However, tricyclic antidepressants a nd steroids as headache prophylactic agents are often more effective than i n non-infected subjects and should be prescribed more generously. Some phar macological interactions have to be considered, e. g. NSAID might increase the toxicity of antiretroviral substances.